Immediate Impact
5 by Nobel laureates 11 from Science/Nature 63 standout
Citing Papers
Renal cell carcinoma
2024 Standout
T-cell-engaging bispecific antibodies in cancer
2023 Standout
Works of Mark N. Stein being referenced
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
2023
Results of an ongoing phase 1/2a dose escalation study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager, in patients with metastatic castration-resistant prostate cancer (mCRPC).
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark N. Stein | 2029 | 2434 | 2261 | 239 | 5.6k | |
| Young Kwang Chae | 1813 | 3005 | 2481 | 263 | 6.1k | |
| Lukas C. Heukamp | 1655 | 1852 | 3381 | 170 | 6.0k | |
| Kenji Sugio | 3236 | 3124 | 2698 | 276 | 7.0k | |
| Shoji Natsugoe | 1404 | 2446 | 2013 | 195 | 5.5k | |
| Jianping Xiong | 1601 | 1914 | 2009 | 186 | 4.8k | |
| Davide Melisi | 1242 | 3347 | 2373 | 158 | 5.7k | |
| Michael J. Pishvaian | 1095 | 3666 | 1907 | 211 | 5.6k | |
| Jian Zhou | 978 | 1949 | 2376 | 213 | 6.2k | |
| Begoña Mellado | 2130 | 1861 | 1931 | 178 | 4.6k | |
| Maurizio Martini | 1041 | 1889 | 2283 | 277 | 6.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...